| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Novavax Inc (NVAX) has 8 insiders with recent SEC Form 4 filings, including 5 buys and 11 sells. NVAX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 264.1K | $2.45M | - | |
| CFO | 145.1K | $1.35M | - | |
| VP | 112.7K | $1.04M | - | |
| VP | 34.9K | $323.3K | - | |
| Dir | 28.5K | $264.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 17, 2015 | Modi Rajiv I. | Director | Sell | 433,053 | $9.01 | $3,901,807.53 | -7.8% | |
| Jun 11, 2015 | Modi Rajiv I. | Director | Sell | 11,185 | $9.00 | $100,665.00 | -0.4% | |
| Jun 10, 2015 | Modi Rajiv I. | Director | Sell | 551,081 | $8.97 | $4,944,943.33 | -5.5% | |
| Jun 4, 2015 | Modi Rajiv I. | Director | Sell | 504,681 | $8.92 | $4,500,072.68 | -4.4% | |
| Jun 1, 2015 | Modi Rajiv I. | Director | Sell | 3,500,000 | $8.74 | $30,600,000.00 | -26.9% | |
| Jan 31, 2015 | Trizzino John86 | SVP, Commercial Operations | Buy | 6,611 | $3.63 | $23,997.93 | +30.0% | |
| Jan 31, 2015 | Herrmann John A III91 | SVP, General Counsel | Buy | 9,869 | $2.28 | $22,501.32 | +59.4% | |
| Jan 31, 2015 | Hahn Timothy Jon | SVP, Manufacturing | Buy | 9,329 | $2.28 | $21,270.12 | +9.2% | |
| Jan 31, 2015 | Wilson Russell P | SVP, Business Development | Buy | 5,050 | $2.28 | $11,514.00 | +8.4% | |
| Jan 31, 2015 | Glenn Gregory M88 | SVP, Research And Development | Buy | 866 | $2.28 | $1,974.48 | New |